Last reviewed · How we verify

NCT05815654

Research and Development of WPAPS Based on the Modern Technology of Traditional Chinese Medicine

Status unknown NA Last updated 18 April 2023
What this trial tests

NA trial testing Warm Palace Analgesic Point Sticker in Dysmenorrhea in 200 participants. Status unknown.

Timeline
20 December 2022
Primary endpoint
31 October 2023
29 February 2024

Quick facts

Lead sponsorHong Kong Baptist University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment200
Start date20 December 2022
Primary completion31 October 2023
Estimated completion29 February 2024
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Hong Kong Baptist University

Who can join

Adults 18 to 35, female only, with Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this double-blind randomized controlled trial is to determine the efficacy of Warm Palace Analgesic Point Sticker in relieving dysmenorrhea compared to placebo sticker. The main questions it aims to answer are: * Can this Warm Palace Analgesic Point Sticker relieve dysmenorrhea? * It is more effective to certain type of TCM syndrome differentiation? Qi stagnation and blood stasis syndrome or cold dampness syndrome? Participants will : * receive test sticker or control sticker five days before every menstruation, once a day, five hours each time, for five consecutive days * take pictures of tongue * fill in some questionnaires after treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dysmenorrhea

Currently open trials in the same condition.

Other Hong Kong Baptist University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05815654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing